导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 50.28% | 55/1050 |
| 近一周 | 1.39% | 148/1104 |
| 近一月 | -1.95% | 348/1103 |
| 近一季 | -13.72% | 829/1092 |
| 近半年 | 34.93% | 64/1070 |
| 近一年 | 55.37% | 72/1018 |
| 近两年 | 163.14% | 92/926 |
| 近三年 | 114.08% | 83/834 |
| 成立以来 | 56.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.90% 113/1070 |
84.22% 90/1101 |
- - |
- - |
| 2025 | 49.73% 197/1065 |
7.67% 243/1014 |
0.59% 644/1038 |
39.72% 197/1050 |
-1.06% 499/1065 |
| 2024 | -2.29% 642/1011 |
-1.14% 378/960 |
-7.16% 751/983 |
11.79% 473/991 |
-4.77% 655/1011 |
| 2023 | -14.65% 507/952 |
0.09% 628/880 |
-3.37% 408/895 |
-8.08% 501/915 |
-4.00% 408/952 |
| 2022 | -24.23% 469/867 |
-18.98% 469/773 |
12.96% 162/806 |
-10.81% 292/845 |
-7.17% 708/867 |
| 2021 | 16.55% 179/740 |
2.12% 86/580 |
17.51% 196/659 |
-8.69% 469/704 |
6.37% 166/740 |
| 2020 | 54.55% 218/554 |
-6.55% 331/419 |
22.83% 228/466 |
14.99% 143/517 |
17.08% 166/554 |
| 2019 | 50.27% 146/410 |
24.95% 708/1146 |
-1.75% 502/1228 |
9.79% 115/390 |
11.49% 122/410 |
| 2018 | -28.05% 192/349 |
- - |
-7.71% 323/990 |
-7.29% 604/1000 |
-10.00% 292/1080 |
| 2017 | 10.26% 132/285 |
- - |
- - |
- - |
- - |
| 2016 | -26.62% 141/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 建信互联网+产业升级股票 VS. 东吴新产业精选股票A(580008) |